531541 — KOBO Biotech Balance Sheet
0.000.00%
Last trade - 00:00- IN₹70.52m
- IN₹1.46bn
- 13
- 12
- 52
- 11
Annual balance sheet for KOBO Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1.28 | 15.6 | 6.45 | 6.45 | 6.96 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 998 | 990 | 175 | 177 | 177 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 1,593 | 1,592 | 375 | 377 | 379 |
| Net Property, Plant And Equipment | 648 | 592 | 417 | 376 | 335 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 2,363 | 2,306 | 792 | 753 | 714 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 2,843 | 2,992 | 1,633 | 1,659 | 1,678 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 3,243 | 3,378 | 2,016 | 2,033 | 2,043 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | -880 | -1,072 | -1,224 | -1,280 | -1,329 |
| Total Liabilities & Shareholders' Equity | 2,363 | 2,306 | 792 | 753 | 714 |
| Total Common Shares Outstanding |